Conexeu Sciences, Inc. (CNXU)
4.97
-0.30
(-5.69%)
USD |
NASDAQ |
Sep 04, 16:00
5.09
+0.12
(+2.41%)
After-Hours: 20:00
Conexeu Sciences SG&A Expense (TTM) : 0.0238M for April 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.0238M |
| January 31, 2026 | 0.007M |
| October 31, 2025 | 0.00 |
| Date | Value |
|---|---|
| April 30, 2025 | 0.00 |
| October 31, 2024 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| AbbVie, Inc. | 14.67B |
| Vericel Corp. | 180.98M |
| ACADIA Pharmaceuticals, Inc. | 620.29M |
| Alnylam Pharmaceuticals, Inc. | 1.318B |
| Anika Therapeutics, Inc. | 52.67M |